Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Algues & Mer is a French marine biotechnology company based on the island of Ouessant, Brittany, that cultivates and harvests macroalgae and extracts active ingredients for cosmetics, nutraceutical, food, veterinary, and agronomic uses. Founded in 1994, the company is particularly known for seaweed-derived polysaccharides including fucoidans produced from fresh certified-organic algae. Its business is commercial rather than drug-development focused, with expertise spanning algae sourcing, controlled processing, extraction, ultrafiltration, and hydrolysis. Algues & Mer has operated as part of Solabia Group since 2016 and appears to remain an active legal entity in France.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Algues & Mer.